Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients | MicrobiomeTrials← Back to trialsNCT06429761
Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-01-02Est. Completion: 2026-10-31
Enrollment target: 100 participants Locations- Research Site, Bangalore, India
- Research Site, Delhi, India
- Research Site, Kochi, India
- Research Site, Mumbai, India
- Research Site, New Delhi, India
- Research Site, Pune, India
- Research Site, Varanasi, India
Other microbiome trials you might be interested in
Triple-Negative Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) i…
Mobile, United StatesEst. completion Dec 16, 2030
Thyroid Nodule
In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap duri…
Busan, South KoreaEst. completion Jun 30, 2024